Projects (32)

Targeted drug delivery to the cornea of the eye via medicated contact lenses and mucoadhesive thin films  (01/02/2019  -  28/12/2022)

Targeted drug delivery to the cornea of the eye via thin-film slow release technology  (01/05/2017  -  31/08/2018)

Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma  (01/10/2019  -  30/12/2022)

Testing of exosome based therapeutics for the eye  (01/09/2022  -  30/11/2022)

The analysis of ocular surface topography and development of novel contact lens design  (01/09/2007  -  31/08/2010)

The biomechanics of the human lamina cribrosa and posterior sclera: Effects of age and glaucoma  (30/09/2016  -  29/09/2018)

The cellular control of corneal development and transparency and generation of biomimetic corneal tissue  (01/08/2015  -  31/01/2019)

The CINY-DOX (Cardiff/Irvine/New York-Duke/Osaka/Xiamen) Initiative in Meibomian Gland Research  (01/01/2023  -  31/03/2023)

The collagen in corneal pathology, and the effects of new therapies for loss of transparency and refractive status  (01/01/2007  -  30/06/2012)

The development of eye tissues via human induced pluripotent stem (IPS) cells  (01/01/2018  -  31/12/2021)

The development of ROCK inhibitor containing corneal storage medium focused on the suppression of apoptosis in corneal endothelial cells  (01/09/2010  -  31/03/2011)

The effectiveness of portable electronic vision enhancement systems (EVES) in comparison to optical magnifiers for near vision activities in visual impairment - the p-EVES study  (01/04/2012  -  31/03/2014)

The enhanced generation of the corneal epithelium from human induced pluripotent stem (hiPS) cells  (01/10/2018  -  30/06/2022)

The genomic basis of human induced pluripotent stem (iPS) cell differentiation into eye-like tissues  (01/11/2019  -  30/09/2024)

The health economic impact of COVID-19  (01/10/2021  -  30/09/2023)

The mint or the hole: Where do optometrists really look when assessing the optic disc?  (01/07/2013  -  11/08/2013)

The Ostracod carapace window as a biomimetic basis for development of a novel eye shield  (01/07/2012  -  31/12/2013)

The role of attention in peripheral vision  (26/10/2018  -  25/04/2019)

The role of inhibitors of apoptosis (IAPs) and caspases in retinal ganglion cell death and dendrite remodelling  (01/10/2007  -  30/09/2010)

The role of the sclera in human glaucoma  (01/01/2012  -  28/02/2015)

The short-term effect of two different lubricant eye drops on tear film properties measured with the Keeler tearscope and Easyview Plus  (01/08/2015  -  12/09/2015)

The targeted inhibition of microglia for the prevention of retinal ganglion cell damage in glaucoma  (01/01/2023  -  31/12/2023)

The therapeutic potential of Genipin as a corneal cross-linking agent: Unlocking a new pathway for the treatment of corneal infection and disease  (01/02/2019  -  31/01/2022)

The ultrastructural basis of corneal dysfunction and the development and optimisation of novel therapeutic strategies  (01/11/2012  -  30/04/2018)

The use of 1050nm OCT to identify changes of optic nerve head pathophysiology in Glaucoma  (01/10/2011  -  30/09/2014)

Three-dimensional ultrahigh resolution ophalmic optical coherence tomography with enhanced penetration  (01/08/2007  -  01/08/2009)

Three dimentional imaging of the ageing and glaucomatous optic nerve head: risk factors for the development of open-angle glaucoma?  (01/08/2008  -  31/07/2009)

To evaluate SEED hydrogel contact lenses in patient groups, and compare to competitor brands  (01/04/2014  -  31/08/2015)

Towards a functional understanding of proteoglycan-collagen associations in the cornea by 3-dimensional electron microscopy of gene-targeted mutants  (10/11/2008  -  09/11/2011)

Translating myopia genetics discoveries into strategies for early detection and mechanistic insight  (30/04/2021  -  29/09/2025)

Trauma Aid  (01/04/2021  -  31/03/2023)

TrkB receptor agonist antibody (AEB Ab# 85) and related TrkB agonist antibodies  (01/11/2017  -  31/10/2018)